Connect
MJA
MJA

TB or not TB: treat to see

Paul L A van Daele, Marleen Bakker, P Martin van Hagen, G Seerp Baarsma and Robert W A M Kuijpers
Med J Aust 2006; 185 (3): . || doi: 10.5694/j.1326-5377.2006.tb00515.x
Published online: 7 August 2006

To the Editor: Uveitis is an intraocular inflammation which potentially leads to permanent loss of vision.1,2 Tuberculosis is considered to be an infrequent infectious cause of uveitis in the developed world. However, its recurrence as a major public health problem raises the possibility that the incidence of tuberculosis-related uveitis in the developed world may rise.3,4 Uveitis in tuberculosis is presumed to result from either direct invasion or a hypersensitivity reaction.


  • 1 Erasmus Medical Center, Rotterdam, The Netherlands.
  • 2 The Eye Hospital, Rotterdam, The Netherlands.


Correspondence: p.l.a.vandaele@erasmusmc.nl

  • 1. Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica 2004; 218: 223-236.
  • 2. Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol 1992; 76: 137-141.
  • 3. Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology 2002; 109: 851-857.
  • 4. Sheu SJ, Shyu JS, Chen LM, et al. Ocular manifestations of tuberculosis. Ophthalmology 2001; 108: 1580-1585.
  • 5. Lindstedt EW, Baarsma GS, Kuijpers RW, van Hagen PM. Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol 2005; 89: 533-536.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.